Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
| ▸ | TEK | Q02763 | 1/20 | 0.31 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2027891 | 0.72 | MAOA (0.48) | MEN1MAPTMAPK1KMT2A | |
| SCHEMBL5712776 | 0.71 | ALOX5 (0.31) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL12795822 | 0.71 | PIM1 (0.43) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL7886293 | 0.67 | ALOX5 (0.37) | ALOX5PTGS2GLS2 | |
| SCHEMBL9624196 | 0.65 | PTGS1 (0.35) | ALOX5 | |
| SCHEMBL12795776 | 0.62 | ALOX5 (0.31) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL26072897 | 0.62 | ALOX5 (0.70) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL57203 | 0.58 | MEN1 (0.50) | KDM4EMEN1USP2TP53CYP3A4 | |
| SCHEMBL11431922 | 0.58 | ALOX5 (0.45) | ALOX5PTGS2KDM4EMEN1USP2 | |
| SCHEMBL27528950 | 0.58 | ACHE (0.53) | MEN1MAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110053276-A1 | MOLECULAR INDICATOR AND PROCESS OF SYNTHESIZING | BATTELLE MEMORIAL INSTITUTE | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053276-A1 | MOLECULAR INDICATOR AND PROCESS OF SYNTHESIZING | MUS81, MKI67, AOC1 | ALOX5 3789/4885PTGS2 2820/4885KDM4E 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.